SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-10-127083
Filing Date
2010-05-24
Accepted
2010-05-24 14:52:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5) d424b5.htm 424B5 222154
2 GRAPHIC g12776cov_pg1.jpg GRAPHIC 3931
3 GRAPHIC g12776suppcov_pg1.jpg GRAPHIC 3632
  Complete submission text file 0001193125-10-127083.txt   234264
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-161442 | Film No.: 10853625
SIC: 2834 Pharmaceutical Preparations